University of Sheffield researchers helped secure FDA approval for a new bone imaging method that could speed up osteoporosis ...
Teva Pharmaceutical Industries recently reported third-quarter 2025 earnings that exceeded analysts’ expectations, advanced an FDA filing for an olanzapine long-acting injectable for schizophrenia, ...
The surrogate endpoint offers an alternative to traditional fracture endpoints used in clinical trials of osteoporosis drugs that have taken typically 2 to 5 years to assess. Test ...
On Monday, the Food and Drug Administration issued a new draft guidance that requires drug manufacturers to conduct long-term nonclinical bone quality studies for osteoporosis treatments. The agency ...
LOS ANGELES - With the launch of the first prescription osteoporosis medication 15 years ago, millions of Americans with the bone-thinning disease began taking the drugs and never looked back. But now ...
Please provide your email address to receive an email when new articles are posted on . It will be “many years” before any new pharmacologic osteoporosis therapies are approved, as there are currently ...
A first-of-its-kind osteoporosis drug lowers the risk of bone fractures better than some existing treatments, two studies suggest, and could soon add a more expensive but easier option to the booming ...
Please provide your email address to receive an email when new articles are posted on . DESTIN, Fla. — Understanding when to switch from one class of drugs to another is critical to maintaining bone ...
A long-term study of the most widely used osteoporosis drug has found that many women can discontinue the drug after five years without increasing their fracture risk for as long as five more years.
An experimental drug has successfully reduced hip and spine fractures in the two largest patient populations at risk for osteoporosis — postmenopausal women and men being treated for prostate cancer — ...
A drug widely used to treat osteoporosis might reduce the risk of Type 2 diabetes, a new study suggests. Taking the drug alendronate, or Fosamax, for at least eight years could potentially reduce a ...